Selected publications: Oliveira B & Ehrenreich H. Pursuing functional connectivity in NMDAR1 autoantibody carriers. Letter to Lancet Psychiatry. 2018 5(1):21-22 Pan H*, Oliveira B*, Dere E, Tapken D, Mitjans M, Seidel J, Wesolowski J, Wakhloo D, Klein-Schmidt C, Ronnenberg A et al. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model. Mol Psychiatry. 2018, in press Castillo-Gómez E*, Oliveira B*, Tapken D*, Bertrand S, Klein-Schmidt C, Pan H, Zafeiriou P, Steiner J, Jurek B, Trippe R et al. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Mol Psychiatry. 2017. epub ahead of print 9 August 2016; doi: 6 10.1038/mp.2016.125. Hadley D, Wu Z-l, Kao C, Kini A, Mohamed-Hadley A, Thomas K, Vazquez L, Qiu H, Mentch F, Pellegrino R, Kim C, Connolly J, AGP Consortium et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nat Commun. 2014 5:4074. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, Thiruvahindrapuram B, Xu X, Ziman R, Wang Z, (…) Oliveira B et al. Convergence of genes and Cellular Pathways dysregulated in Autism Spectrum Disorders. Am J Hum Genet. 2014. 1;94 (5):677-94.
|